Skip to Content

MYLAN 2046 MYLAN 2046 (Tacrolimus 1 mg)

Pill with imprint MYLAN 2046 MYLAN 2046 is Blue & Gray, Capsule-shape and has been identified as Tacrolimus 1 mg. It is supplied by Mylan Pharmaceuticals Inc..

Tacrolimus is used in the treatment of organ transplant, rejection prophylaxis; graft-versus-host disease; organ transplant, rejection reversal; crohn's disease and belongs to the drug class calcineurin inhibitors. Risk cannot be ruled out during pregnancy. Tacrolimus 1 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for MYLAN 2046 MYLAN 2046

Tacrolimus

Imprint:
MYLAN 2046 MYLAN 2046
Strength:
1 mg
Color:
Blue & Gray
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Calcineurin inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
lactose anhydrous
ferrosoferric oxide
silicon dioxide
croscarmellose sodium
gelatin
hypromelloses
lactose monohydrate
magnesium stearate
sodium lauryl sulfate
titanium dioxide
ferric oxide yellow
FD&C Blue No. 1
FD&C Red No. 3
D&C Yellow No. 10
FD&C Blue No. 2
FD&C Red No. 40
propylene glycol
shellac
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
51079-0818 UDL Laboratories Inc

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide